Prolonged impacts of COVID-19-associated cystitis: A study on long-term consequences

Table 2 Outcomes assessment

	Initial urologic assessment (10-14 wk)		Follow up urologic assessment (21-28 mo)
	OAB symptom score median (range)	QoL score median (range)	OAB symptom score median (range)	Qol score median (range)
New symptoms (n = 250)a	18 (12-21)	19 (16-24)	9 (4-21)	9 (7-20)
Worsening symptoms (n = 100)b	19 (17-21)c	20 (19-20)c	13 (5-21)	14 (6-20)
Female (n = 140)	18 (15-21)	19 (16-21)	8 (4-21)	7 (6-22)
Male (n = 210)	18 (12-20)	19 (16-20)	7 (5-20)	8 (6-23)

^a30 patients lost to follow up.

^b10 patients lost to follow up.

^cPre-COVID OAB and QoL median score: 8 (range 4-10) and 9 (8-10) respectively.

CAC: COVID-associated cystitis; OAB: Overactive bladder; QoL: Quality of life.